Oct. 28th to Nov. 2nd, 2019. Shanghai Desano Chemical Pharmaceutical Co., Ltd. received the on-site inspection by Therapeutic Goods Administration (TGA) of Australia. The inspection covered the whole GMP system and related products and proposed suggestion for further improvement. In Jan. 2020, response to inspection report was submitted. In Apr. 2020, closing letter of inspection and TGA GMP certificate were obtained. With the completion of the inspection, another milestone of continuous quality improvement of Shanghai Desano Chemical Pharmaceutical Co., Ltd. was achieved.